Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890536901> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2890536901 abstract "e15732Background: nal-IRI is a nanoliposomal formulation of irinotecan. In the primary analysis of the pivotal NAPOLI-1 Phase-3 trial, nal-IRI+5-FU/LV significantly improved median overall survival..." @default.
- W2890536901 created "2018-09-27" @default.
- W2890536901 creator A5000928175 @default.
- W2890536901 creator A5006886614 @default.
- W2890536901 creator A5008330168 @default.
- W2890536901 creator A5016769451 @default.
- W2890536901 creator A5018333718 @default.
- W2890536901 creator A5029987315 @default.
- W2890536901 creator A5037074954 @default.
- W2890536901 creator A5047813339 @default.
- W2890536901 creator A5049680516 @default.
- W2890536901 creator A5071888326 @default.
- W2890536901 creator A5075059160 @default.
- W2890536901 creator A5080900202 @default.
- W2890536901 creator A5082631947 @default.
- W2890536901 creator A5087184017 @default.
- W2890536901 date "2016-05-20" @default.
- W2890536901 modified "2023-09-30" @default.
- W2890536901 title "Quality-adjusted time without symptoms or toxicity (Q-TWiST) of nanoliposomal irinotecan (nal-IRI; MM-398) plus 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone in metastatic pancreatic adenocarcinoma (mPAC) patients (pts) previously treated with gemcitabine-based therapy." @default.
- W2890536901 doi "https://doi.org/10.1200/jco.2016.34.15_suppl.e15732" @default.
- W2890536901 hasPublicationYear "2016" @default.
- W2890536901 type Work @default.
- W2890536901 sameAs 2890536901 @default.
- W2890536901 citedByCount "0" @default.
- W2890536901 crossrefType "journal-article" @default.
- W2890536901 hasAuthorship W2890536901A5000928175 @default.
- W2890536901 hasAuthorship W2890536901A5006886614 @default.
- W2890536901 hasAuthorship W2890536901A5008330168 @default.
- W2890536901 hasAuthorship W2890536901A5016769451 @default.
- W2890536901 hasAuthorship W2890536901A5018333718 @default.
- W2890536901 hasAuthorship W2890536901A5029987315 @default.
- W2890536901 hasAuthorship W2890536901A5037074954 @default.
- W2890536901 hasAuthorship W2890536901A5047813339 @default.
- W2890536901 hasAuthorship W2890536901A5049680516 @default.
- W2890536901 hasAuthorship W2890536901A5071888326 @default.
- W2890536901 hasAuthorship W2890536901A5075059160 @default.
- W2890536901 hasAuthorship W2890536901A5080900202 @default.
- W2890536901 hasAuthorship W2890536901A5082631947 @default.
- W2890536901 hasAuthorship W2890536901A5087184017 @default.
- W2890536901 hasConcept C121608353 @default.
- W2890536901 hasConcept C126322002 @default.
- W2890536901 hasConcept C143998085 @default.
- W2890536901 hasConcept C2776694085 @default.
- W2890536901 hasConcept C2780259306 @default.
- W2890536901 hasConcept C2780456651 @default.
- W2890536901 hasConcept C29730261 @default.
- W2890536901 hasConcept C526805850 @default.
- W2890536901 hasConcept C71924100 @default.
- W2890536901 hasConcept C90924648 @default.
- W2890536901 hasConceptScore W2890536901C121608353 @default.
- W2890536901 hasConceptScore W2890536901C126322002 @default.
- W2890536901 hasConceptScore W2890536901C143998085 @default.
- W2890536901 hasConceptScore W2890536901C2776694085 @default.
- W2890536901 hasConceptScore W2890536901C2780259306 @default.
- W2890536901 hasConceptScore W2890536901C2780456651 @default.
- W2890536901 hasConceptScore W2890536901C29730261 @default.
- W2890536901 hasConceptScore W2890536901C526805850 @default.
- W2890536901 hasConceptScore W2890536901C71924100 @default.
- W2890536901 hasConceptScore W2890536901C90924648 @default.
- W2890536901 hasLocation W28905369011 @default.
- W2890536901 hasOpenAccess W2890536901 @default.
- W2890536901 hasPrimaryLocation W28905369011 @default.
- W2890536901 isParatext "false" @default.
- W2890536901 isRetracted "false" @default.
- W2890536901 magId "2890536901" @default.
- W2890536901 workType "article" @default.